Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cFMS tyrosine kinase inhibitor ARRY-382
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ARRAY-382-201, NCI-2016-01576, NCT02880371
Start Over